By conducting experiments, we confirmed that three key genes (SEC61B, NPLOC4, and EIF2S1) have the potential to be molecular targets, providing valuable understanding of the mechanisms involved in PAH. This evidence concerns the gene NPLOC4 and pulmonary arterial hypertension.